Search

Your search keyword '"Birling MC"' showing total 80 results

Search Constraints

Start Over You searched for: Author "Birling MC" Remove constraint Author: "Birling MC" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
80 results on '"Birling MC"'

Search Results

1. BIN1 genetic risk factor for Alzheimer is sufficient to induce early structural tract alterations in entorhinal cortex-dentate gyrus pathway and related hippocampal multi-scale impairments

2. BIN1 genetic risk factor for Alzheimer is sufficient to induce early structural tract alterations in entorhinal-hippocampal area and memory-related hippocampal multi-scale impairments

3. Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia Syndrome

4. The mammalian gene function resource: the international knockout mouse consortium

5. Impact of essential genes on the success of genome editing experiments generating 3313 new genetically engineered mouse lines.

6. Improving laboratory animal genetic reporting: LAG-R guidelines.

7. The COL6A5-p.Glu2272* mutation induces chronic itch in mice.

8. The Rogdi knockout mouse is a model for Kohlschütter-Tönz syndrome.

10. Changes in social behavior with MAPK2 and KCTD13/CUL3 pathways alterations in two new outbred rat models for the 16p11.2 syndromes with autism spectrum disorders.

11. Development of HPV16 mouse and dog models for more accurate prediction of human vaccine efficacy.

12. A human dynein heavy chain mutation impacts cortical progenitor cells causing developmental defects, reduced brain size and altered brain architecture.

13. IL-3 produced by T cells is crucial for basophil extravasation in hapten-induced allergic contact dermatitis.

14. A conditional null allele of Dync1h1 enables targeted analyses of dynein roles in neuronal length sensing.

15. Increased On-Target Rate and Risk of Concatemerization after CRISPR-Enhanced Targeting in ES Cells.

16. CRISMERE Chromosome Engineering in Mouse and Rat.

17. Large-Scale Functional Assessment of Genes Involved in Rare Diseases with Intellectual Disabilities Unravels Unique Developmental and Behaviour Profiles in Mouse Models.

18. Ts66Yah, a mouse model of Down syndrome with improved construct and face validity.

19. Keratinocyte-derived cytokine TSLP promotes growth and metastasis of melanoma by regulating the tumor-associated immune microenvironment.

20. The Human SCN9A R 185 H Point Mutation Induces Pain Hypersensitivity and Spontaneous Pain in Mice.

23. Importing genetically altered animals: ensuring quality.

24. The Human SCN10A G1662S Point Mutation Established in Mice Impacts on Mechanical, Heat, and Cool Sensitivity.

25. Integrative approach to interpret DYRK1A variants, leading to a frequent neurodevelopmental disorder.

26. Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome.

27. Distinct roles of α- and β-tubulin polyglutamylation in controlling axonal transport and in neurodegeneration.

28. Droplet digital PCR or quantitative PCR for in-depth genomic and functional validation of genetically altered rodents.

29. Reliable and robust droplet digital PCR (ddPCR) and RT-ddPCR protocols for mouse studies.

30. Universal Southern blot protocol with cold or radioactive probes for the validation of alleles obtained by homologous recombination.

31. Evidence that corticofugal propagation of ALS pathology is not mediated by prion-like mechanism.

32. A resource of targeted mutant mouse lines for 5,061 genes.

33. Targeting the RHOA pathway improves learning and memory in adult Kctd13 and 16p11.2 deletion mouse models.

34. Targeting Morphine-Responsive Neurons: Generation of a Knock-In Mouse Line Expressing Cre Recombinase from the Mu-Opioid Receptor Gene Locus.

35. Conditional switching of KIF2A mutation provides new insights into cortical malformation pathogeny.

36. Modeling Down syndrome in animals from the early stage to the 4.0 models and next.

37. Transgenic mouse models expressing human and macaque prion protein exhibit similar prion susceptibility on a strain-dependent manner.

38. Severe head dysgenesis resulting from imbalance between anterior and posterior ontogenetic programs.

39. The neuroanatomy of Eml1 knockout mice, a model of subcortical heterotopia.

40. TUBG1 missense variants underlying cortical malformations disrupt neuronal locomotion and microtubule dynamics but not neurogenesis.

41. Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1a.

42. A new mouse model of ARX dup24 recapitulates the patients' behavioral and fine motor alterations.

43. Ptchd1 deficiency induces excitatory synaptic and cognitive dysfunctions in mouse.

44. Nox4 genetic inhibition in experimental hypertension and metabolic syndrome.

45. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression.

46. Modeling human disease in rodents by CRISPR/Cas9 genome editing.

47. Mouse models of 17q21.31 microdeletion and microduplication syndromes highlight the importance of Kansl1 for cognition.

48. Efficient and rapid generation of large genomic variants in rats and mice using CRISMERE.

49. Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia Syndrome.

50. Aneuploidy screening of embryonic stem cell clones by metaphase karyotyping and droplet digital polymerase chain reaction.

Catalog

Books, media, physical & digital resources